IBRI IN THE NEWS: Diabetes Research Center awards pilot funding to six Indiana scientists

December 10, 2021

Six scientists have been recognized with Pilot & Feasibility (P&F) Awards from the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine, an NIDDK-designated Diabetes Research Center. Each awardee received $50,000 to advance studies related to diabetes and metabolic diseases.

Since its inception in 2015, the CDMD P&F Program has awarded more than $1.3 million to 26 scientists statewide. Past awardees represent IU School of Medicine, IU Bloomington, IU-Terre Haute, IU-Fort Wayne, IUPUI School of Science, the Indiana Biosciences Research Institute and Purdue University.

The program boasts a historically successful return on investment. To date, awardees have secured nearly $30 million in additional funding from the NIH—including 24 independent research awards (R awards)—and private foundations following their CDMD P&F awards.

This year’s awardees include 6 investigators from IU, Purdue, and the Indiana Biosciences Research Institute.

Scott Canfield, PhD
Assistant Professor of Anatomy, Cell Biology & Physiology
IU School of Medicine-Terre Haute
Project title: Hyperglycemia-Induced BBB Dysfunction in Alzheimer's Disease

Chad C. Carroll, PhD
Assistant Professor of Health and Kinesiology
Purdue University
Project title: Mechanisms Underlying Poor Tendon Healing with Diabetes

Gregory Henderson, PhD
Assistant Professor of Nutrition Science
Purdue University
Project title: Targeting plasma free fatty acids through a novel approach as a potential intervention for insulin resistance

Andrew Templin, PhD
Assistant Professor of Medicine-Endocrinology, IU School of Medicine
Assistant Investigator, Indiana BioSciences Research Institute Diabetes Center
Project title: Susceptibility of primary islet beta cells to RIPK3-mediated necroptosis

I-Chen Yu, PhD
Assistant Research Professor of Anatomy Cell Biology & Physiology
IU School of Medicine-Fort Wayne
Project title: Deciphering the molecular crosstalk of obesity-related cerebrovascular dysfunction in vascular cognitive impairment and dementia

Li Zhang, PhD
Assistant Investigator
Indiana Biosciences Research Institute
Project title: Suppression of antigen-specific monoclonal antibodies in humanized spontaneous Type 1 diabetes mice

To read the full article, go to the Indiana University School of Medicine website.